Celcuity LLC (NASDAQ:CELC) — Market Cap & Net Worth
Market Cap & Net Worth: Celcuity LLC (CELC)
Celcuity LLC (NASDAQ:CELC) has a market capitalization of $4.10 Billion ($4.10 Billion) as of June 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #4081 globally and #1408 in its home market, demonstrating a -4.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Celcuity LLC's stock price $88.55 by its total outstanding shares 46271259 (46.27 Million). Review Celcuity LLC (CELC) financial obligations to assess the company's total debt and financial obligations.
Celcuity LLC Market Cap History: 2017 to 2026
Celcuity LLC's market capitalization history from 2017 to 2026. Data shows growth from $876.84 Million to $4.10 Billion (23.23% CAGR).
Index Memberships
Celcuity LLC is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.44 Trillion | 0.17% | #95 of 976 |
|
NASDAQ Composite
IXIC
|
$40.95 Trillion | 0.01% | #468 of 3165 |
Weight: Celcuity LLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Celcuity LLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Celcuity LLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CELC by Market Capitalization
Companies near Celcuity LLC in the global market cap rankings as of June 16, 2026.
Key companies related to Celcuity LLC by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #438 globally with a market cap of $63.06 Billion USD.
- UCB SA (BR:UCB): Ranked #544 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #563 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $444.93 |
| #438 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $63.06 Billion | $612.14 |
| #544 | UCB SA | BR:UCB | $49.68 Billion | €274.90 |
| #563 | Argen-X | BR:ARGX | $47.14 Billion | €783.60 |
Celcuity LLC Historical Marketcap From 2017 to 2026
Between 2017 and today, Celcuity LLC's market cap moved from $876.84 Million to $ 4.10 Billion, with a yearly change of 23.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $4.10 Billion | -11.22% |
| 2025 | $4.62 Billion | +661.96% |
| 2024 | $605.69 Million | -10.16% |
| 2023 | $674.17 Million | +4.00% |
| 2022 | $648.26 Million | +6.22% |
| 2021 | $610.32 Million | +44.00% |
| 2020 | $423.84 Million | -13.91% |
| 2019 | $492.33 Million | -55.65% |
| 2018 | $1.11 Billion | +26.60% |
| 2017 | $876.84 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 15th, 2026 the market cap of Celcuity LLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.10 Billion USD |
| MoneyControl | $4.10 Billion USD |
| MarketWatch | $4.10 Billion USD |
| marketcap.company | $4.10 Billion USD |
| Reuters | $4.10 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Celcuity LLC
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2… Read more